Related Experiment Video
Updated: Sep 13, 2025
06:10
Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
3.4K
Post-infarct effusive-constrictive pericarditis with a percutaneous left ventricular assist device: a case report
Jonah Kan1, Louise Asleson1, Karla Inestroza2
1Department of Internal Medicine, Mayo Clinic, 200 1st Street SW, Rochester, MN 55905, USA.
European Heart Journal. Case Reports
|July 28, 2025
Summary
Effusive-constrictive pericarditis (ECP) can complicate treatment for heart attack patients requiring mechanical support. Early recognition and management are key for recovery.
Area of Science:
- Cardiology
- Intensive Care Medicine
- Cardiovascular Surgery
Background:
- Effusive-constrictive pericarditis (ECP) is a rare condition characterized by pericardial effusion and constriction.
- ECP can lead to hemodynamic instability due to compression of cardiac chambers.
Observation:
- A patient with acute myocardial infarction and cardiogenic shock developed ECP while supported by a percutaneous left ventricular assist device (PVAD).
- The patient experienced hemodynamic instability, pulsus paradoxus, and PVAD suction alarms, initially responsive to pericardiocentesis but later developing constrictive physiology.
Findings:
- ECP presents with combined features of cardiac tamponade and constrictive pericarditis.
- PVAD suction alarms in this case were likely due to ECP-induced reduction in left ventricular preload.
Implications:
- ECP should be considered in patients with persistent hemodynamic compromise after pericardiocentesis.
- Prompt diagnosis and anti-inflammatory treatment of ECP can improve outcomes in critically ill patients.
Keywords:
Cardiac tamponadeCardiogenic shockCase reportEffusive-constrictive pericarditisPercutaneous left ventricular assist device (PVAD)Pulsus paradoxusMore Related Videos
Related Concept Videos
01:29Cardiomyopathy V: Interprofessional Care
34
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
34
01:17Pericarditis III: Medical Management
26
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
26
01:30Cardiomyopathy II: Dilated Cardiomyopathy
23
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
23
01:22Pericarditis I: Introduction
23
Pericarditis is defined as the inflammation of the pericardium, the thin, sac-like membrane surrounding the heart. This condition can cause significant chest pain and other symptoms, often necessitating medical intervention. The pericardium has two layers: the inner visceral layer and the outer parietal layer, separated by a small amount of fluid that reduces friction during heartbeats.Types of PericarditisPericarditis can be classified into several types based on the duration and nature of the...
23
01:19Pericarditis II: Clinical Features and Diagnostic Tests
28
Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
28
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
52
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
52